Medicine News and Research

RSS

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

Researchers identify cause that leads to age-related hearing loss

Age-related hearing loss is the most common sensory disorder among the elderly. But scientists are still trying to figure out what cellular processes govern or contribute to the loss.

11 Nov 2009

Anemia-reducing medications linked to deep vein thrombosis in cancer patients

Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. The findings will be published online on Nov. 10, 2009 in the Journal of the National Cancer Institute (ahead of the Dec. 2, 2009 print edition).

11 Nov 2009

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.

11 Nov 2009

Occupational contact dermatitis and asthma are most common work-related health issues, says new research

Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

11 Nov 2009

Study: Face time at doctor visits expanding, not dwindling

Researchers have found that, contrary to conventional wisdom backed by "a more than 10 percent drop" in physician pay and consumer complaints, doctors are actually spending more time with their patients than they used to, the Los Angeles Times' Booster Shots blog reports.

11 Nov 2009

Cerimon Pharmaceuticals acquires rights to develop and commercialize diclofenac sodium patch in Europe

Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in Europe, including most countries in the European Union, Turkey, Switzerland, Norway, the Balkan countries and Iceland. Terms of the agreement were not disclosed. Cerimon initially acquired the U.S. rights to develop and commercialize the patch formulation of diclofenac in 2005.

10 Nov 2009

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Catalyst Pharmaceutical Partners, Inc. today reported that a team of neuroscientists at The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System (LIJ) has received a $1.2 million grant from the U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate addiction.

10 Nov 2009

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

10 Nov 2009

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.

10 Nov 2009

AMA sticks with House bill endorsement

The American Medical Association, the official physician lobby, reiterated its endorsement of the House bill Monday. The Associated Press/The Washington Post reports that the AMA "on Monday rebuffed dissident members and voted to stick with support for ongoing health reform efforts, while reiterating wariness over proposals that threaten doctors' pocketbooks and independence.

10 Nov 2009

Tokai Pharmaceuticals commences TOK-001 Phase 1/2 clinical trial for treatment of castration resistant prostate cancer

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.

10 Nov 2009

National Pain Summit calls for better pain care in America

Pain medicine physicians from the American Academy of Pain Medicine (AAPM) continued to advance the call for better pain care as they joined with physician leaders from across the country in a closed-door National Pain Summit that took place adjacent to an AMA meeting last week in Houston, Texas.

10 Nov 2009

Health care reform should benefit shift workers: Circadian Age

Circadian Age, Inc. – ‘Working Nights’ – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is concerned with making sure that any health care reform will benefit the 25 million Americans working shifts. These workers represent 10% of the insured population, but incur 17% of the health care costs.

10 Nov 2009

UT Southwestern Medical Center professor and Olympian Dr. Peter Snell knighted

Dr. Peter Snell, adjunct associate professor of internal medicine at UT Southwestern Medical Center and a three-time Olympic gold medalist for his native New Zealand, has won yet another honor - a knighthood in his homeland.

10 Nov 2009

America's attention is focused on physical and psychological well being of its soldiers

With the tragic events at Fort Hood in Texas fresh in our minds, this week's observance of Veterans Day, and President Obama's pending decision on future troop levels in Afghanistan, the nation's attention is firmly focused on the physical and psychological well being of those who serve in America's armed forces.

10 Nov 2009

Tufts University researchers identify strategies to improve community-based participatory research partnerships

Researchers from Tufts University and their community-based colleagues have identified several strategies to improve community-based participatory research (CBPR) partnerships.

10 Nov 2009

Trinity Health to install Elsevier's online CDS solutions

Elsevier (http://www.elsevier.com), a world leader in healthcare and medical publishing and online solutions, today announced that Trinity Health (http://www.trinity-health.org), the nation's fourth largest Catholic health system with 44 hospitals across eight states, will install seven of Elsevier's online clinical decision support (CDS) solutions to meet the evolving needs of its thousands of physicians, nurses, pharmacists and allied health professionals for evidence-based clinical content.

10 Nov 2009

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.

10 Nov 2009

Prolonged ED wait time is associated with poor clinical outcomes

One in four emergency department patients in 2006 waited longer to be evaluated by a clinician than recommended at triage, an increase from one in five in 1997, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Nov 2009

Medicine News and Research

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

Researchers identify cause that leads to age-related hearing loss

Anemia-reducing medications linked to deep vein thrombosis in cancer patients

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Occupational contact dermatitis and asthma are most common work-related health issues, says new research

Study: Face time at doctor visits expanding, not dwindling

Cerimon Pharmaceuticals acquires rights to develop and commercialize diclofenac sodium patch in Europe

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Aduro BioTech raises funds through its Series A-1 financing

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

AMA sticks with House bill endorsement

Tokai Pharmaceuticals commences TOK-001 Phase 1/2 clinical trial for treatment of castration resistant prostate cancer

National Pain Summit calls for better pain care in America

Health care reform should benefit shift workers: Circadian Age

UT Southwestern Medical Center professor and Olympian Dr. Peter Snell knighted

America's attention is focused on physical and psychological well being of its soldiers

Tufts University researchers identify strategies to improve community-based participatory research partnerships

Trinity Health to install Elsevier's online CDS solutions

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

Prolonged ED wait time is associated with poor clinical outcomes

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News